Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.24p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 0
  • Market Cap: £5.05m
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Huw Jones 3,184,793 £7,484
Toni Hänninen 1,000,000 £2,350

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 422,727,272 £993,409
First Equity Limited 179,000,000 £420,650
T and I Limited 160,000,000 £376,000
Oberon Investments Limited 80,475,000 £189,116
Spreadex Ltd 80,009,545 £188,022
Andrew Leach 80,000,000 £188,000
Simon Gibeon 71,400,000 £167,790
Rathbones Investment Management Ltd 25,789,246 £60,605
Sarum Investment SICAV Plc 25,700,000 £60,395
Octopus Investments Nominees Limited 21,875,000 £51,406
Octopus Investments Nominees Limited 21,875,000 £51,406
Vulpes Investment Management Pte Ltd 20,554,191 £48,302
InterTrader Limited 16,560,033 £38,916
Seneca Partners Limited 16,301,456 £38,308
North West Fund (Biomedical) LP 16,186,446 £38,038
Richard Griffiths and family 14,408,000 £33,859
AXA Framlington Investment Management Limited 13,399,724 £31,489
Chelverton Asset Management 12,500,000 £29,375
RAB Capital 8,750,000 £20,562
David and Monique Newlands 8,314,815 £19,540
Newlands Capital 8,314,815 £19,540
Ali Mortazavi 3,400,000 £7,990
PARTNERS INVESTMENT COMPANY LLP 3,114,089 £7,318
Letzone Limited 2,664,000 £6,260
Beaufort Securities Limited 2,457,568 £5,775
South Yorkshire Investment Capital Fund LP 1,394,550 £3,277

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.24p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 0
Shares Issued 2,148.96m
Market Cap £5.05m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.48% below the market average43.48% below the market average43.48% below the market average43.48% below the market average43.48% below the market average
61.70% above the sector average61.70% above the sector average61.70% above the sector average61.70% above the sector average61.70% above the sector average
Price Trend
94.86% below the market average94.86% below the market average94.86% below the market average94.86% below the market average94.86% below the market average
82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average
Income Not Available
Growth
16.74% below the market average16.74% below the market average16.74% below the market average16.74% below the market average16.74% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Theracryf Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page